This compound is a pharmaceutical intermediate featuring a tert-butoxycarbonyl-protected amino group and a hydroxyl group on a cyclohexane ring with defined cis stereochemistry. It is primarily used as a building block in the synthesis of more complex pharmaceutical compounds.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 224309-64-2
CIS-4-(TERT-BUTOXYCARBONYLAMINO)CYCLOHEXANOL
Pharmaceutical intermediate for synthesis
CIS-4-(TERT-BUTOXYCARBONYLAMINO)CYCLOHEXANOL
Pharmaceutical intermediate for API synthesis
Ethyl 4-amino-2,2-difluorobutanoate hydrochloride
pharmaceutical intermediate for API synthesis
4,6-Dichloro-pyridazine-3-carboxylic acid lithium salt monohydrate
pharmaceutical intermediate
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-
Pharmaceutical intermediate for deucravacitinib synthesis
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
Pharmaceutical intermediate for deucravacitinib
tert-butyl N-(4-hydroxycyclohexyl)carbamate
DQARDWKWPIRJEH-UHFFFAOYSA-N
CC(C)(C)OC(=O)NC1CCC(CC1)O